May 2026
The global large molecule drug discovery outsourcing market size was evaluated at USD 3.20 billion in 2025 and is predicted to hit around USD 7.67 billion by 2035, growing at a CAGR of 9.14%.
April 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.66 billion in 2025, with a CAGR of 9.70%.
January 2026
The global small molecule drug discovery market size is calculated at USD 95.63 billion in 2025 and is projected to hit around USD 204.06 billion by 2035 with a CAGR of 7.87%.
January 2025
The global drug discovery outsourcing market size was valued at USD 4.15 billion in 2024 and is projected to hit around USD 8.43 billion by 2034 with a CAGR of 7.34%.
May 2026
The global drug discovery market size was evaluated at USD 71.89 billion in 2025 and is projected to hit around USD 171.36 billion by 2035 with a CAGR of 9.07%.
May 2026
The global in-silico drug discovery market size is estimated to hit around USD 11.8 billion by 2035 increasing from USD 4.17 billion in 2025, with a CAGR of 10.96%.
May 2026
The global computational medicine and drug discovery software market size was evaluated at USD 10.90 billion in 2025 and is predicted to hit around USD 60.52 billion by 2035, growing at a CAGR of 18.70%.
April 2026
The global drug discovery informatics market size is estimated at USD 4.81 billion in 2025 and is projected to surpass around USD 13.68 billion by 2035 at a CAGR of 11.02%.
March 2026
The global computer-aided drug discovery market size is projevted to hit around USD 14.38 billion by 2035 from USD 4.72 billion in 2025 with a CAGR of 11.78%.
February 2026
The global gastro-retentive drug delivery systems outsourcing market size is expected to increase from USD 2.04 billion in 2025 to hit around USD 3.86 billion by 2035, growing at a CAGR of 6.58%.
January 2026
The generative AI in drug discovery market size reached USD 260.56 million in 2025 and is estimated to hit around USD 2,724.15 million by 2035, at a CAGR of 26.45%.
November 2025
The global biomarker discovery outsourcing services market size is evaluated at USD 17.42 billion in 2025 and is predicted to hit around USD 86.74 billion by 2034, growing at a CAGR of 19.53%.
November 2025
The artificial intelligence (AI) in drug discovery market size is predicted to surpass around USD 17.81 billion by 2035 from USD 6.93 billion in 2025 with a solid CAGR of 9.90%.
September 2025
The AI-driven drug discovery platforms market is growing as pharmaceutical companies leverage AI to accelerate target identification and lead optimization.
January 2025
The drug discovery services market size was estimated at USD 21.26 billion in 2024 and is expected to hit around USD 79.71 billion by 2034, growing at a CAGR of 14.13% from 2025 to 2034.
August 2025
The U.S. pharmaceutical CDMO market size was calculated at USD 40.52 billion in 2024 and is predicted to reach around USD 83.25 billion by 2034, with a CAGR of 7.47%.
August 2025
The global pharmaceutical CRO market size was evaluated at USD 44.58 billion in 2024 and is projected to attain around USD 91.20 billion by 2034, with a CAGR of 7.42%.
June 2026
The global drug screening market size is exhibited at USD 10.55 billion in 2025 and is anticipated to attain around USD 43.72 billion by 2035 with a CAGR of 15.28%.
June 2026
The global DNA repair drugs market size reached USD 9.36 billion in 2025 and is predicted to surpass around USD 33.11 billion by 2035 with a notable CAGR of 13.47%.
June 2026
The U.S. over the counter (OTC) drugs market size is expected to increase from USD 24.81 billion in 2025 and is predicted to hit USD 46.67 billion by 2035, with a CAGR of 6.52%.
June 2026
The global drug and gene delivery devices market size is projected to hit around USD 1,875.96 million by 2035 from USD 792.67 million in 2025, with a CAGR of 9.00%.
June 2026
The global epilepsy drug market size is projected to attain around USD 19.67 billion by 2035 from USD 11.88 billion in 2025 with a CAGR of 5.17%.
June 2026
The global critical care drugs market size was evaluated at USD 1.22 billion in 2025 and is projected to surge around USD 2.00 billion by 2035, with a CAGR of 5.07%.
June 2026
The global pingueculum drugs market size was evaluated at USD 832.14 million in 2025 and is predicted to hit around USD 1,660.04 million by 2035, growing at a CAGR of 7.15%.
May 2026
The global hyperlipidemia drugs market size is calculated at USD 23.85 billion in 2025 and is projected to surpass USD 35.24 billion by 2035 with a CAGR of 3.98%.
May 2026
The global pain management drugs market size was valued at USD 87.19 billion in 2025 and is expected to hit around USD 130.8 billion by 2035, growing at a CAGR of 4.14%.
May 2026
The global nanotechnology drug delivery market size was valued at USD 105.95 billion in 2025 and is expected to hit around USD 222.96 billion by 2035, growing at a CAGR of 7.72%.
May 2026
The U.S. pain management drugs market size was estimated at USD 32.79 billion in 2025 and is projected to hit around USD 46.50 billion by 2035, at a CAGR of 3.56%.
May 2026
The global HIV drugs market size is estimated at USD 38.47 billion in 2025 and is projected to hit around USD 69.88 billion by 2035, growing at a CAGR of 6.15%.
May 2026
The global over the counter (OTC) drugs market size is expected to increase from USD 135.25 billion in 2025 and is expected to hit USD 256.87 billion by 2035, growing at a CAGR of 6.62%